Fills for Generic Viagra Continue To Surge: GoodRx Monthly Report

Tori Marsh
Tori Marsh, MPH, is on the Research Team at GoodRx, and is the resident expert on drug pricing and savings.
Posted on

Blockbuster erectile dysfunction drug Viagra (sildenafil) went generic in 2017, and since then, fills for generic sildenafil have surged — up 18% in June alone.

The GoodRx Index also showed the following drug trends in June:

This data reflects overall US prescriptions (not fills using GoodRx) and comes from several sources, including pharmacies and insurers, providing a representative sample of nationwide US prescription drug volume.

Fills for sildenafil continue to surge

Back in December 2017, generic sildenafil was released at around $30 per pill, a 50% discount from expensive brand-name version Viagra. Since that release, the number of prescription fills for the generic has skyrocketed, and this past June alone, fills increased by 18%. This growth in prescription fills shows how many more men are willing to pay for their erectile dysfunction medication now that it is more affordable.

We’re through the worst of allergy season

Last month, we reported that fills for five popular allergy medications (montelukast, cetirizine, hydroxyzine, fluticasone, and loratadine) were up 30% since the start of allergy season in February. It seems as if we may have seen the worst of allergies this year, as fills for the above allergy medications have dropped by 15% since the end of last month.

The most popular drugs in June

Here are the 10 most popular drugs based on a representative sample of fills at US pharmacies. They reflect overall US prescriptions, not fills using GoodRx.

  1. Atorvastatin
  2. Levothyroxine
  3. Lisinopril
  4. Hydrocodone/acetaminophen
  5. Amlodipine
  6. Omeprazole
  7. Ventolin
  8. Fluticasone
  9. Ibuprofen
  10. Prednisone

The most expensive drugs in June

These are the 10 most expensive outpatient drugs in the US based on list prices for a typical one-month prescription.

  1. Actimmune – $53,321
  2. Daraprim – $45,000
  3. Cinryze – $44,140
  4. Chenodal – $42,750
  5. Myalept – $42,137
  6. H.P. Acthar – $38,892
  7. Juxtapid – $36,992
  8. Firazyr – $32,468
  9. Harvoni – $31,500
  10. Cuprimine – $31,426

Some other news from June

Drugs featured in this story

Filed under